Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-0070-2019

Drug recall · October 24, 2018

Cicatricure recall

Why: Subpotent Drug: low out of specification assay results for the octocrylene and avobenzone ingredients.

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Cicatricure, Scar Cream + Sunscreen SPF 30 (avobenzone 3%, octocrylene 10%, oxybenzone 6%), 0.7 oz. (19.8 g) tube, Distributed by: Genomma Lab USA Inc., Houston, TX 77027, UPC 6 50067 00018 7.

Lots / codes

Lot: 163241K, Exp. October 2018

Quantity
7,944 tubes
Company
Product Quest Manufacturing LLC, Daytona Beach, FL
Distribution
Nationwide in the USA
Initiated
August 3, 2018 · Voluntary: Firm initiated
Classified
October 16, 2018
Reported
October 24, 2018
Ended
March 30, 2021
How notified
Letter

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.